Carmela Caballero
@Carmela_surgery
Followers
401
Following
5K
Statuses
2K
Surgeon, researcher, advocate for transformative and collaborative cancer research
Brussels, Belgium
Joined November 2017
RT @SOS_Pk: #CancerCon17 2025: ABSTRACT SUBMISSION Only a few days to go! Submit your abstracts to #CancerCon17 at
0
6
0
RT @BIGxResearch: Today at #SABCS24 ! 10-year results of BIG 2-04 #SUPREMO trial, excited to see Dr. Ian Kunkler at his oral presentation:…
0
1
0
RT @BIGxResearch: Data from #AURORA is contributing to knowledge about #breastcancer in older #patients. #SABCS24 @BCRFcure @SanMartino_Ge…
0
10
0
RT @BIGxResearch: From #SABCS24: Some collaborators of the BIG-Asia collaboration reunited! 🌏 @Wonshikhan @HanByoel_Lee_MD @Carmela_surgery…
0
2
0
RT @BIGxResearch: Reunited with @GRASPtweets at #SABCS24! Together, we're driving #collaboration forward to unlock new frontiers in #resear…
0
7
0
RT @BIGxResearch: Thank you, #SABCS24, for these inspiring days of learning, #collaboration, & meaningful discussions. Here's to advancing…
0
3
0
RT @BIGxResearch: 👏 Congratulations to @ElisaAgostinett on receiving the #SABCS24 “Early Investigator #Award” and on her work and presentin…
0
14
0
RT @GBG_Forschung: Our poster "Biomarkers in metastatic #breastcancer with brain metastases – a subanalysis of matched tumor samples from t…
0
3
0
RT @GRASPtweets: Hey @SABCSSanAntonio Attendees — make sure you've added Educational Session 12: The Biology and Treatment Implications of…
0
10
0
RT @BIGxResearch: #SABCS24 P3-11-03 poster on results of phase 2 #DECRESCENDO study: Neoadjuvant treatment w/ an anthracycline-free regimen…
0
13
0
RT @EMittendorfMD: Outstanding session on optimizing local regional therapy in breast cancer led by @TariKingMD @BrighamSurgery @DFCI_Breas…
0
9
0
RT @ABCGlobalAll: Full room for The Lancet #breastcancer Commission session at #SABCS24. We are very proud of being here sharing the Advanc…
0
3
0
RT @GuiNaderMarta: Happy to present at #SABCS24 the results of 4 studies exploring: - Prognostic/predictive biomarkers of CDK4/6i beyond p…
0
10
0
RT @SABCSSanAntonio: PARP inhibition after standard treatment improved long-term survival in patients with high-risk, BRCA-positive breast…
0
15
0
RT @Icro_Meattini: Honoured and excited for having contributed to the #SABCS24 Faculty at the clinical case discussion session with giants…
0
10
0
RT @aftimosp: Christos Vaklavas maps the path of development of novel agents targeting PIK3CA and discusses phase 1 results of RLY-2608, ST…
0
11
0
RT @TanjaSpanic: Congrats @LazarPo31787807 for your great work and results on VANESSA study - Treatment patterns and clinical outcomes acco…
0
7
0
RT @MammaMiaMagazin: Great presentation by Dr Maria Karsten from 🇩🇪 presenting results of the #ProB study + discussion by Gabrielle Rocque.…
0
11
0
RT @BIGxResearch: #Mindact exploratory analysis showed HER2 low #breastcancer has heterogeneous profile, genomic risk & clinical outcomes.…
0
6
0
RT @BIGxResearch: BIG, with @GroupeUnicancer, @GustaveRoussy, @uniofwarwick & 22 partners, is launching #Path4Young: a European project to…
0
2
0